-
公开(公告)号:US20160067205A1
公开(公告)日:2016-03-10
申请号:US14847428
申请日:2015-09-08
IPC分类号: A61K31/203 , A61K39/395 , C07K16/40
CPC分类号: C07K16/2896 , A61K31/203 , A61K39/39558 , A61K2039/505 , A61P35/00 , C07K2317/34 , C07K2317/51 , C07K2317/56 , C07K2317/565 , C07K2317/732 , C07K2317/734 , C07K2317/92 , A61K2300/00
摘要: The present invention relates to combination therapies with anti-CD38 antibodies and all-trans retinoic acid.
摘要翻译: 本发明涉及与抗CD38抗体和全反式视黄酸的组合疗法。
-
2.Combination therapies for heme malignancies with Anti-CD38 antibodies and survivin inhibitors 审中-公开
标题翻译: 用抗CD38抗体和存活蛋白抑制剂组合治疗血红素恶性肿瘤公开(公告)号:US20160367663A1
公开(公告)日:2016-12-22
申请号:US15189577
申请日:2016-06-22
发明人: Parul Doshi , Henk M. Lokhorst , Tuna Mutis
IPC分类号: A61K39/395 , A61K9/00 , A61K38/47 , A61K31/497
摘要: The present invention relates to combination therapies for heme malignancies with anti-CD38 antibodies and survivin inhibitors.
摘要翻译: 本发明涉及用抗CD38抗体和存活蛋白抑制剂的血红素恶性肿瘤的组合疗法。
-
公开(公告)号:US20170107295A1
公开(公告)日:2017-04-20
申请号:US15386391
申请日:2016-12-21
IPC分类号: C07K16/28 , A61K39/395 , A61K31/203
CPC分类号: C07K16/2896 , A61K31/203 , A61K39/39558 , A61K2039/505 , A61P35/00 , C07K2317/34 , C07K2317/51 , C07K2317/56 , C07K2317/565 , C07K2317/732 , C07K2317/734 , C07K2317/92 , A61K2300/00
摘要: The present invention relates to combination therapies with anti-CD38 antibodies and all-trans retinoic acid.
-
4.
公开(公告)号:US10668149B2
公开(公告)日:2020-06-02
申请号:US15189577
申请日:2016-06-22
发明人: Parul Doshi , Henk M. Lokhorst , Tuna Mutis
IPC分类号: A61K39/395 , A61K9/00 , C07K16/28 , A61K31/497 , A61K38/47 , A61K39/00
摘要: The present invention relates to combination therapies for heme malignancies with anti-CD38 antibodies and survivin inhibitors.
-
公开(公告)号:US10604580B2
公开(公告)日:2020-03-31
申请号:US15386391
申请日:2016-12-21
IPC分类号: A61K39/395 , C07K16/28 , A61K31/203 , A61P35/00 , A61K39/00
摘要: The present invention relates to combination therapies with anti-CD38 antibodies and all-trans retinoic acid.
-
-
-
-